Evidence map›Paper›PMID 35393949›Full record

ArticleJCI insight2022

KLF5 protects the intestinal epithelium against Th17 immune response in a murine colitis model.

Jason Shieh, Timothy H Chu, Yang Liu, Julie Kim, Ainara Ruiz de Sabando, Soma Kobayashi, Sui Y Zee, Brian S Sheridan, Agnieszka B Bialkowska, Vincent W Yang

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Cells · 2025
    Review
  3. Review
  4. Key Interleukins in Inflammatory Bowel Disease-A Review of Recent Studies.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Article
  7. Cell cycle (Georgetown, Tex.) · 2023
    Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Jason ShiehDepartment of Medicine.
Timothy H ChuDepartment of Microbiology and Immunology.
Yang LiuDepartment of Medicine.
Julie KimDepartment of Medicine.
Ainara Ruiz de SabandoDepartment of Medicine.
Soma KobayashiDepartment of Medicine.
Sui Y ZeeDepartment of Pathology, and.
Brian S SheridanDepartment of Microbiology and Immunology.
Agnieszka B BialkowskaDepartment of Medicine.
Vincent W YangDepartment of Medicine.
Stony Brook School · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008444 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI FROHMAN, MICHAEL A. · 1992 to 2024
$12.6M
REGULATION OF INTESTINAL EPITHELIAL CELL PROLIFERATIONR01DK052230 · NIDDK · STATE UNIVERSITY NEW YORK STONY BROOK · PI Vincent W Yang · 1997 to 2026
$8.7M
Mechanisms regulating intestinal resident memory CD8 T cell developmentR21AI137929 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI SHERIDAN, BRIAN S · 2018 to 2019
$432k
NIAID NIH HHS R21 AI137929NIDDK NIH HHS R01 DK052230NIGMS NIH HHS T32 GM008444
6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) is a chronic illness characterized by dysregulated immune cascades in the intestines, in which the Th17 immune response plays an important role. We demonstrated that mice with intestinal epithelium-specific deletion of Krüppel-like factor 5 (Klf5) developed Th17-dependent colonic inflammation. In the absence of KLF5, there was aberrant cellular localization of phosphorylated STAT3, an essential mediator of the Th17-associated cytokine, IL-22, which is required for epithelial tissue regeneration. In contrast, mitigation of IL-17A with anti-IL-17A neutralizing antibody attenuated colitis in Klf5-deficient mice. There was also a considerable shift in the colonic microbiota of Klf5-deficient mice that phenocopied human IBD. Notably, the inflammatory response due to Klf5 deletion was alleviated by antibiotic treatment, implicating the role of microbiota in pathogenesis. Finally, human colitic tissues had reduced KLF5 levels when compared with healthy tissues. Together, these findings demonstrated the importance of KLF5 in protecting the intestinal epithelium against Th17-mediated immune and inflammatory responses. The mice described herein may serve as a potential model for human IBD.

Indexed as

ColitisInflammatory Bowel DiseasesKruppel-Like Transcription FactorsAdaptive ImmunityAnimalsIntestinal MucosaMiceMice, Inbred C57BLKlf5 protein, mouseKruppel-Like Transcription FactorsCytokinesGastroenterologyInflammationInflammatory bowel diseaseMouse models

Identifiers

PMID35393949
PMCPMC9057631
OpenAlexW4223638209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.